Benson M D, Skinner M, Cohen A S
Ann Intern Med. 1977 Jul;87(1):31-4. doi: 10.7326/0003-4819-87-1-31.
A patient with familial Mediterranean fever and amyloidosis who received a cadaver renal transplant 6 1/2 years ago was studied to determine the relation of the serum precursor of secondary amyloid (SAA) to the clinical course and to the deposition of amyloid in the transplant. Amyloid fibrils extracted from the patient's kidneys contained protein AA as a major constituent, which identified the amyloid as secondary. Protein AA antiserum was used in an indirect immunofluorescent technique to stain amyloid deposits in sections of the original kidney. A renal biopsy at 2 years showed no amyloid, but a renal biopsy at 4 years showed amyloid. Serum levels of SAA from 3 years before transplant to 6 years after transplant were elevated throughout most of the course.
一名6年半前接受尸体肾移植的家族性地中海热和淀粉样变性患者接受了研究,以确定继发性淀粉样蛋白(SAA)的血清前体与临床病程以及移植肾中淀粉样蛋白沉积之间的关系。从患者肾脏中提取的淀粉样纤维以蛋白质AA作为主要成分,这确定该淀粉样蛋白为继发性。蛋白质AA抗血清用于间接免疫荧光技术,以对原肾切片中的淀粉样蛋白沉积物进行染色。2年时的肾活检未显示淀粉样蛋白,但4年时的肾活检显示有淀粉样蛋白。从移植前3年到移植后6年,大部分病程中SAA的血清水平均升高。